Literature DB >> 21176633

[Chinese risk stratification scoring system for coronary artery bypass grafting].

Zhe Zheng1, Lu Zhang.   

Abstract

OBJECTIVE: To construct a scoring system for the prediction of in-hospital mortality in Chinese patients undergoing coronary artery bypass grafting (CABG).
METHODS: From 2007 to 2008, complete clinical information of 9564 consecutive CABG patients was collected from Chinese coronary artery bypass grafting registry which recruited patients from 43 Chinese centers. This database was randomly divided into developmental and validation subsets (9:1). A risk model was developed using logistic regression. Calibration and discrimination characteristics were assessed in the validation dataset. Thresholds were defined for each model to distinguish different risk groups. The risk model was compared with EuroSCORE system in the validation dataset.
RESULTS: In the developmental dataset, calibration by Hosmer-Lemeshow (HL) test was P = 0.44 and discrimination by area under ROC (AUC) was 0.80. In the validation dataset, HL test was P = 0.34, AUC was 0.78. The performance turned out good for all three risk groups. Superiority were found over EuroSCORE (HL P = 0.60; AUC 0.73). The scoring system identified 11 risk factors (with weights in brackets): age over 65 (65 - 69, 3; 70 - 74, 5; over 75, 6), preoperative NYHA stage (NHYA III, 3; NHYA IV, 7), chronic renal failure (6), extracardiac arteriopathy (5), chronic obstructive pulmonary disease (4), Preoperative atrial fibrillation or flutter (within two weeks) (2), left ventricular ejection fraction < 50% (4), other than elective surgery (5), combined valve procedure (4), preoperative critical state (4), BMI (> 24 kg/m(2), -2; < 18 kg/m(2), 5).
CONCLUSION: This study constructs a simple, objective and accurate risk stratification system for Chinese patients undergoing CABG using the most up-to-date data.

Entities:  

Mesh:

Year:  2010        PMID: 21176633

Source DB:  PubMed          Journal:  Zhonghua Xin Xue Guan Bing Za Zhi        ISSN: 0253-3758


  2 in total

1.  Assessment of three risk evaluation systems for patients aged ≥70 in East China: performance of SinoSCORE, EuroSCORE II and the STS risk evaluation system.

Authors:  Lingtong Shan; Wen Ge; Yiwei Pu; Hong Cheng; Zhengqiang Cang; Xing Zhang; Qifan Li; Anyang Xu; Qi Wang; Chang Gu; Yangyang Zhang
Journal:  PeerJ       Date:  2018-02-23       Impact factor: 2.984

2.  Validation of SinoSCORE for isolated CABG operation in East China.

Authors:  Xiue Ma; Yunqian Wang; Lingtong Shan; Zhengqiang Cang; Chang Gu; Nianyi Qu; Qifan Li; Jun Li; Zhenhua Wang; Yangyang Zhang
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.